885 studies found for:    Open Studies | "Hypoglycemic Agents"
Show Display Options
Rank Status Study
21 Recruiting Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Placebo;   Drug: Exenatide
22 Unknown  A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Repaglinide
23 Recruiting Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin glargine U300 HOE901;   Drug: Insulin glargine HOE901
24 Recruiting Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Mellitus Patients Not Achieving Glycemic Targets on Basal Insulin With/Without Anti-Hyperglycemic Agents
Condition: Diabetes Mellitus, Type 2 (T2DM)
Interventions: Device: Bolus Insulin Patch (Calibra Finesse);   Device: Insulin Pen (Novo-Nordisk FlexPen®)
25 Unknown  Observational Registry for Basal Insulin Treatment Study (ORBIT)
Condition: Diabetes
Intervention:
26 Recruiting Linagliptin Inpatient Trial
Condition: Type 2 Diabetes
Interventions: Drug: Linagliptin;   Drug: Basal Bolus;   Drug: Linagliptin + 50% Glargine dose on discharge;   Drug: Linagliptin + 80% Glargine
27 Not yet recruiting A Clinical Trial Analyzing Effects of Prokinetic Drug on the Blood Glucose in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Mosapride;   Drug: Placebo
28 Recruiting Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)
Conditions: Type 2 Diabetes Mellitus;   Cardiovascular Disease
Interventions: Drug: Liraglutide;   Drug: Sitagliptin
29 Recruiting Treatment of Recurrent Brain Tumors: Metabolic Manipulation Combined With Radiotherapy
Condition: Brain Neoplasms
Interventions: Radiation: Partial brain re-irradiation.;   Drug: Metformin;   Behavioral: low carbohydrate diet
30 Recruiting Comparison of Two Titration Programs of Adding Insulin Detemir to OADs in Poorly Controlled Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Behavioral: Active titration algorithm;   Behavioral: Usual titration algorithm
31 Unknown  Effects of Alogliptin on Pancreatic Beta Cell Function
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Alogliptin;   Drug: Metformin 750 mg
32 Recruiting Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia
Conditions: Type 1 Diabetes Mellitus;   Nocturnal Hypoglycemia;   Recurrent Severe Hypoglycaemia
Interventions: Drug: Insulin aspart/glargine;   Drug: Insulin aspart/degludec
33 Recruiting The Practical Evidence of Antidiabetic Combination Therapy in Korea
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: alogliptin;   Drug: Pioglitazone;   Drug: alogliptin + pioglitazone
34 Unknown  The Effects of Hypolipemic and Antidiabetic Treatment on Cytokines
Conditions: Diabetes;   Dyslipidemia;   Inflammation;   Cytokines
Intervention: Drug: Metformin 1000mg, simvastatin 10mg and fenofibrate 100mg
35 Unknown  Hypoglycemia and Autonomic Nervous System Function
Condition: Hypoglycemia
Interventions: Drug: Eplerenone;   Drug: Placebo
36 Recruiting Treatment of Type 2 Diabetes With Long Acting Basal Insulin in Jordan
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: INSULIN GLARGINE
37 Unknown  Shiga Progression of Diabetes, Nephropathy and Retinopathy
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Pioglitazone add on to SU or biguanide;   Drug: SU or Biguanide
38 Not yet recruiting A Drug-drug Interaction Study Between Daclatasvir and Metformin
Conditions: Hepatitis C;   Diabetes Mellitus;   Insulin Resistance
Interventions: Drug: Daclatasvir;   Drug: Metformin
39 Unknown  An Open-randomized, Balanced, Crossover Bioequivalence Study to Compare One MR Tablet of 60 mg Gliclazide and Two MR Tablets of 30 mg Gliclazide in Healthy Subjects
Conditions: Hyperglycemia;   Diabetes
Intervention:
40 Recruiting Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Liraglutide;   Drug: Placebo;   Drug: Mixed Meal Tolerance Test with paracetamol

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years